A life free from epilepsy is possible. Your research could help to achieve this.

Our research is funded after rigorous scrutiny of grant applications in a multi-stage process including independent expert opinion, peer review and interviews, so you can be assured of the quality of the research funded.

DTC Logo

APPLICATIONS NOW OPEN

ERUK has launched a Doctoral Training Centre (DTC) Grant Scheme with the aim of capacity building the UK epilepsy research environment. ERUK invites applications from research institutes to apply for multiple linked PhD studentships to commence 2021-2023. We welcome applications from both individual research institutes as well as collaborative applications shared across more than one institute. ERUK DTCs may wish to align with other funded training schemes and infrastructure already in place within the research institute(s).

Deadline for applications 16.00, 29 May 2020 

APPLY FOR FUNDING

Our annual grant round is now closed and will reopen in May 2020. To read about the grants available through our annual grant round, click on the links below:

pilot studies stacked

Up to £30,000 across 2 years

Awarded to a research team to test a novel research idea and provide evidence to leverage larger funding amounts

Apply for funding
Endeavour project grants stacked

Up to £200,000 across 3 years

Awarded to a team with a track record in epilepsy research to investigate a research question based on prior evidence.

Apply for funding
Emerging leader fellowship stacked

Up to £300,000 across 4 years

Awarded to an early career researcher to develop their skills and knowledge in order to become a leader in epilepsy research.

Apply for funding

Read more about our funded research here.

Who to contact?

If you would like further information, please contact Caoimhe Twohig-Bennett.

Other ERUK funding

From time to time, ERUK works with third sector partners to commission research that will accelerate innovations for people with epilepsy and influence clinical practice and health policy.  For further information, please contact our Chief Executive, Maxine Smeaton, in the first instance.